BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38533430)

  • 1. Serum cell division cycle 42 reflects the development and progression of diabetic nephropathy in patients with diabetes mellitus.
    Yu H; Ma J; Gu Y; Zou W; Zhao N
    Exp Ther Med; 2024 May; 27(5):185. PubMed ID: 38533430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Kawasaki R; Ohashi Y; Akanuma Y; Yamada N; Sone H; Yamashita H; Katayama S;
    Diabetes Care; 2013 Sep; 36(9):2803-9. PubMed ID: 23620478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum JKAP reflects Th2 and Th17 cell levels, and diabetic nephropathy risk and severity in diabetes mellitus patients.
    Tong M; Gu C; Yu Q; Ma J
    Biomark Med; 2023 Sep; 17(17):701-710. PubMed ID: 38179996
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral blood mitochondrial DNA copy number as a novel potential biomarker for diabetic nephropathy in type 2 diabetes patients.
    Al-Kafaji G; Aljadaan A; Kamal A; Bakhiet M
    Exp Ther Med; 2018 Aug; 16(2):1483-1492. PubMed ID: 30116398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 as a prognostic biomarker for diabetic nephropathy.
    Hodeib H; Hagras MM; Abdelhai D; Watany MM; Selim A; Tawfik MA; Elsebaey MA; Elshweikh SA
    Diabetes Metab Syndr Obes; 2019; 12():325-331. PubMed ID: 30936732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased serum myonectin concentrations in diabetic nephropathy patients.
    Zhang J; Hu W; Lin P; Wang R
    Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients.
    Chang YH; Lin KD; Wang CL; Hsieh MC; Hsiao PJ; Shin SJ
    Diabetes Metab Res Rev; 2008; 24(8):629-34. PubMed ID: 18973209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between serum carnosinase concentration and renal damage in diabetic nephropathy patients.
    Zhou Z; Liu XQ; Zhang SQ; Qi XM; Zhang Q; Yard B; Wu YG
    Amino Acids; 2021 May; 53(5):687-700. PubMed ID: 33811534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microalbuminuria and Traditional Serum Biomarkers of Nephropathy among Diabetic Patients at Mbarara Regional Referral Hospital in South Western Uganda.
    Kiconco R; Rugera SP; Kiwanuka GN
    J Diabetes Res; 2019; 2019():3534260. PubMed ID: 31934589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Albuminuria and Diabetic Retinopathy in Type-II Diabetes Mellitus Patients.
    Dash S; Chougule A; Mohanty S
    Cureus; 2022 Feb; 14(2):e21927. PubMed ID: 35155044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of lymphocyte count in autoimmune diabetic nephropathy.
    Xiang Z; Liu W; Fu S; Hu J; Yang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1639-1649. PubMed ID: 38432854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes.
    Deng X; Zhao L; Guo C; Yang L; Wang D; Li Y; Xia H; Wang C; Cai Z; Li L; Zhao Z; Yuan G
    Diabetes Metab Syndr Obes; 2020; 13():4341-4351. PubMed ID: 33223841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes.
    Hou NN; Kan CX; Huang N; Liu YP; Mao EW; Ma YT; Han F; Sun HX; Sun XD
    World J Diabetes; 2021 Jan; 12(1):47-55. PubMed ID: 33520107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203.
    Eroglu İ; Korkmaz H; Ozturk KH; Sirin FB; Sevik S; Afsar B
    Minerva Endocrinol (Torino); 2022 Sep; 47(3):314-324. PubMed ID: 33331738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.